Bristol Myers Squibb (BMY) FCF Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-7.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-537.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-911.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
1,568.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
534.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
913.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
9,115.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-1,716.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
| Mar 31, 2026 |
-1,716.00 |
| Dec 31, 2025 |
-1,312.00 |
| Sep 30, 2025 |
1,835.00 |
| Jun 30, 2025 |
1,225.00 |
| Mar 31, 2025 |
-1,543.00 |
| Dec 31, 2024 |
172.00 |
| Sep 30, 2024 |
131.00 |
| Jun 30, 2024 |
-744.00 |
| Mar 31, 2024 |
-1,148.00 |
| Dec 31, 2023 |
642.00 |
| Sep 30, 2023 |
2,015.00 |
| Jun 30, 2023 |
-2,856.00 |
| Mar 31, 2023 |
-1,105.00 |
| Dec 31, 2022 |
166.00 |
| Sep 30, 2022 |
-872.00 |
| Jun 30, 2022 |
-1,343.00 |
| Mar 31, 2022 |
1,052.00 |
| Dec 31, 2021 |
-2,348.00 |
| Sep 30, 2021 |
2,444.00 |
| Jun 30, 2021 |
929.00 |
| Mar 31, 2021 |
1,495.00 |
| Dec 31, 2020 |
1,192.00 |
| Sep 30, 2020 |
-756.00 |
| Jun 30, 2020 |
1,709.00 |
| Mar 31, 2020 |
2,323.00 |
| Dec 31, 2019 |
385.00 |
| Sep 30, 2019 |
1,779.00 |
| Jun 30, 2019 |
2,651.00 |
| Mar 31, 2019 |
3,074.00 |
| Dec 31, 2018 |
4,069.00 |
| Sep 30, 2018 |
1,141.00 |
| Jun 30, 2018 |
1,732.00 |
| Mar 31, 2018 |
590.00 |
| Dec 31, 2017 |
689.00 |
| Sep 30, 2017 |
732.00 |
| Jun 30, 2017 |
165.00 |
| Mar 31, 2017 |
-153.00 |
| Dec 31, 2016 |
-680.00 |
| Sep 30, 2016 |
-126.00 |
| Jun 30, 2016 |
-3,123.00 |
| Mar 31, 2016 |
347.00 |
| Dec 31, 2015 |
-180.00 |
| Sep 30, 2015 |
-11,190.00 |
| Jun 30, 2015 |
-2,524.00 |
| Mar 31, 2015 |
710.00 |
| Dec 31, 2014 |
-1,734.00 |
| Sep 30, 2014 |
-990.00 |
| Jun 30, 2014 |
557.00 |
| Mar 31, 2014 |
499.00 |
| Dec 31, 2013 |
-152.00 |
| Sep 30, 2013 |
-412.00 |
| Jun 30, 2013 |
1,458.00 |
| Mar 31, 2013 |
-2,114.00 |
| Dec 31, 2012 |
-704.00 |
| Sep 30, 2012 |
9,180.00 |